Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more


(Plasmid #115906)


Item Catalog # Description Quantity Price (USD)
Plasmid 115906 Standard format: Plasmid sent in bacteria as agar stab 1 $85

This material is available to academics and nonprofits only.


  • Vector backbone
  • Backbone manufacturer
  • Backbone size w/o insert (bp) 6700
  • Total vector size (bp) 9000
  • Vector type
    Mammalian Expression
  • Selectable markers
    Neomycin (select with G418)

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
  • Growth Strain(s)
  • Copy number


  • Gene/Insert name
    DENV2 NS2B3 protease
  • Species
    Dengue Virus Serotype 2, Strain NGC
  • Insert Size (bp)
  • GenBank ID
  • Promoter CMV
  • Tag / Fusion Protein
    • V5 tag (C terminal on insert)

Cloning Information

Resource Information

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pcDNA_DENV2-NS2B3_V5 was a gift from Alan Rothman (Addgene plasmid # 115906 ; ; RRID:Addgene_115906)
  • For your References section:

    Dengue virus downregulates TNFR1- and TLR3-stimulated NF-kappaB activation by targeting RIPK1. Udawatte DJ, Lang DM, Currier JR, Medin CL, Rothman AL. Front Cell Infect Microbiol. 2022 Oct 14;12:926036. doi: 10.3389/fcimb.2022.926036. eCollection 2022. 10.3389/fcimb.2022.926036 PubMed 36310878